5-Amino-2-(trifluoromethyl)benzimidazole → HCID 66712085, 화합물

HRID 1262375

반응식

HRID 1262375 반응식
[CH:1]1([CH2:4][S:5]([C:8]2[CH:9]=[C:10]([C:14]3[N:22]4[C:17]([CH:18]=[N:19][C:20](SC)=[N:21]4)=[CH:16][CH:15]=3)[CH:11]=[CH:12][CH:13]=2)(=[O:7])=[O:6])[CH2:3][CH2:2]1.[F:25][C:26]([F:38])([F:37])[C:27]1[NH:28][C:29]2[CH:35]=[C:34]([NH2:36])[CH:33]=[CH:32][C:30]=2[N:31]=1>>[CH:1]1([CH2:4][S:5]([C:8]2[CH:9]=[C:10]([C:14]3[N:22]4[C:17]([CH:18]=[N:19][C:20]([NH:36][C:34]5[CH:33]=[CH:32][C:30]6[N:31]=[C:27]([C:26]([F:38])([F:37])[F:25])[NH:28][C:29]=6[CH:35]=5)=[N:21]4)=[CH:16][CH:15]=3)[CH:11]=[CH:12][CH:13]=2)(=[O:7])=[O:6])[CH2:3][CH2:2]1

참가 물질

3

반응물 2

HCID 193455-Amino-2-(trifluoromethyl)benzimidazoleHCID 667121477-(3-Cyclopropylmethanesulfonyl-phenyl)-2-methylsulfanyl-pyrrolo[2,1-f][1,2,4]triazine

생성물 1

HCID 66712085HCID 66712085, 화합물

실험 절차

Following the synthetic and purification procedures described in Example 1293d, 7-(3-cyclopropylmethanesulfonyl-phenyl)-2-methylsulfanyl-pyrrolo[2,1-f][1,2,4]triazine (75 mg, 0.20 mmol) was coupled with 2-trifluoromethyl-3H-benzimidazol-5-ylamine (68.3 mg, 0.340 mmol) at 105° C. for 86 h to afford the title compound. Yield of TFA salt: 25 mg (22%) of brown powder; LC/MS: 513 (M+H); HPLC: 97% pure, RT=3.43 min; 1H NMR: (DMSO, δ) 9.60 (s, 1H), 8.97 (s, 1H), 8.53 (d, J=7.9, 1H), 8.41 (s, 1H), 7.90 (s, 1H), 7.81 (d, J=7.9, 1H), 7.70 (m, 2H), 7.60 (d, J=8.8, 1H), 7.21 (d, J=4.8, 1H), 6.91 (d, J=4.8, 1H), 3.20 (d, J=7.2, 2H), 0.77 (m, 1H), 0.32 (m, 2H), −0.01 (m, 2H).

후처리

  1. custompurification procedures

출처 및 근거

ORD 기록
ord-2651d12541b94b848cac041d43315352
출처 데이터셋
uspto-grants-2013_06
특허 번호
US08471005B2

연결된 노트

불러오는 중…